Star Health to meet investors in London on June 29
Star Health and Allied Insurance Company Limited will meet analysts and institutional investors in London on June 29, 2026, to present its Q4FY26 performance and strategic outlook. The insurer will engage with five major investment firms, including Jupiter Asset Management and Schroder Investment Management, to update stakeholders on recent financial results.

*this image is generated using AI for illustrative purposes only.
Star Health and Allied Insurance Company Limited will meet analysts and institutional investors in London on June 29, 2026, to present its Q4FY26 performance and strategic outlook. The insurer will engage with five major investment firms, including Jupiter Asset Management and Schroder Investment Management, to update stakeholders on recent financial results.
The meeting follows Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Due to business exigencies on the part of the investors, the company provided intimation at a shorter notice than usual. Star Health expressed regret for the short notice and committed to ensuring timely intimation for future meetings.
The schedule includes in-person sessions with the following firms:
| Firm | Mode | Time (UK time) |
|---|---|---|
| Jupiter Asset Management | In-person | 10:15-11:15 |
| AGDEM | In-person | 12:00-13:00 |
| Federated Hermes Ltd | In-person | 13:30-14:30 |
| Schroder Investment Management | In-person | 15:00-16:00 |
| USS Investment Management | In-person | 16:15-17:15 |
The presentation for the meeting will be made available on the company's website. The disclosure is subject to changes that may occur due to exigencies on the part of the analysts or investors.
Historical Stock Returns for Star Health Insurance
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.30% | +0.98% | +12.65% | +33.79% | +41.06% | -34.33% |
What strategic initiatives is Star Health likely to highlight to attract UK institutional investors given the competitive insurance landscape?
How might the Q4FY26 performance influence Star Health's valuation and investor sentiment in the global market?
What are the potential long-term benefits of engaging with top-tier asset managers like Jupiter and Schroder for Star Health's growth?































